ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases
Clinical trial NCT00294437 · TERMINATED
Trial details
- NCT number
- NCT00294437
- Sponsor
- Central European Cooperative Oncology Group
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-12-01
- Primary completion
- 2003-12-01
- Enrollment
- 376
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.